DEXCOM INC (DXCM)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for DXCM
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| DXCM | Lead Independent Director; Chair | 65 | ["Former Executive Vice President and Chief Financial Officer of Tocagen, Inc. from 2017 to 2020","Former Senior Vice President and Chief Financial Officer of Amylin Pharmaceuticals until its acquisition by Bristol Myers Squibb from 2000 to 2012","More than two decades of financial leadership in healthcare","Deep expertise in audit oversight, capital allocation, and financial strategy","Audit and financial leadership experience at public healthcare companies","Public company board experience","Member of the Corporate Directors Forum","B.A. in Business Economics, UC Santa Barbara","audit committee financial expert","financial qualifications"] | ["Audit Committee"] | 2026 |